- Home
- NPKI vs PLRX Comparison
NPKI vs PLRX Comparison
Compare NPKI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- PLRX
- Stock Information
- Founded
- NPKI 1932
- PLRX 2015
- Country
- NPKI United States
- PLRX United States
- Employees
- NPKI N/A
- PLRX N/A
- Industry
- NPKI Metal Fabrications
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- NPKI Industrials
- PLRX Health Care
- Exchange
- NPKI Nasdaq
- PLRX Nasdaq
- Market Cap
- NPKI 722.7M
- PLRX 84.7M
- IPO Year
- NPKI N/A
- PLRX 2020
- Fundamental
- Price
- NPKI $8.57
- PLRX $1.16
- Analyst Decision
- NPKI Strong Buy
- PLRX Hold
- Analyst Count
- NPKI 1
- PLRX 10
- Target Price
- NPKI $12.00
- PLRX $9.79
- AVG Volume (30 Days)
- NPKI 924.8K
- PLRX 1.4M
- Earning Date
- NPKI 08-04-2025
- PLRX 08-06-2025
- Dividend Yield
- NPKI N/A
- PLRX N/A
- EPS Growth
- NPKI N/A
- PLRX N/A
- EPS
- NPKI N/A
- PLRX N/A
- Revenue
- NPKI $233,299,000.00
- PLRX N/A
- Revenue This Year
- NPKI $15.28
- PLRX N/A
- Revenue Next Year
- NPKI $9.62
- PLRX N/A
- P/E Ratio
- NPKI N/A
- PLRX N/A
- Revenue Growth
- NPKI 312.30
- PLRX N/A
- 52 Week Low
- NPKI $4.76
- PLRX $1.10
- 52 Week High
- NPKI $8.88
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- NPKI N/A
- PLRX 34.14
- Support Level
- NPKI N/A
- PLRX $1.23
- Resistance Level
- NPKI N/A
- PLRX $1.43
- Average True Range (ATR)
- NPKI 0.00
- PLRX 0.11
- MACD
- NPKI 0.00
- PLRX -0.02
- Stochastic Oscillator
- NPKI 0.00
- PLRX 3.92
About NPKI NPK International Inc. Common Stock
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.